Hydroxychloroquine in hospitalized COVID ‐19 patients: Real world experience assessing mortality

ConclusionsWe report from a large retrospective multinational database analysis of COVID ‐19 outcomes with HCQ and overall mortality in hospitalized patients. There was no statistically significant increase in mortality and mortality/arrhythmia with HCQ or HCQ/AZ.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - October 12, 2020 Category: Drugs & Pharmacology Authors: Frank H. Annie, Cristian Sirbu, Keely R. Frazier, Mike Broce, B. Daniel Lucas Tags: ORIGINAL RESEARCH ARTICLE Source Type: research